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Cortical and papillary absorptive defects in gentamicin nephrotoxicity.
Renal function was examined in rats given daily injections of gentamicin
(100 to 150 mg/kg) for 10 to 14 days. Whole kidney inulin clearance fell
and urine volume increased. Single nephron GFR of surface nephrons
varied. Some nephrons had no filtration, some had low rates, and some
had high rates. Abnormal renal tubular epithelial inulin permeability
was demonstrated by microinjection. Micropuncture of individual
nephrons early and later in their course demonstrated reduced fluid
reabsorption along the proximal convoluted tubule of superficial neph-
rons. Rates of fluid delivery to the late proximal and distal tubule were
elevated. The rate of fluid reabsorption in the superficial loop of Henle
was increased. Maximal urine osmolality and papillary tissue content of
urea was reduced. The polyuria, therefore, results from decreased fluid
reabsorption by proximal tubules and, probably, by papillary collecting
ducts. The decrease in proximal fluid reabsorption is probably second-
ary to impaired solute reabsorption. A decrease in collecting duct fluid
absorption can be attributed to the observed decrease in papillary solute
concentration.
Anomalies d'absorption corticale et papillaire dans Ia néphrotoxicité
par Ia gentamicine. La fonction rénale a été examinée chez des rats
recevant des injections journalieres de gentamicine (100 a 150 mg/kg)
pendant 10 a l4jours. La clearance de l'inuline du rein entier a chute, et
le volume urinaire a augmente. Le debit de filtration glomerulaire
néphronique individuel des néphrons superficiels a vane. Certains
néphrons n'avaient pas de filtration, certains avaient des debits faibles
et certains avaient des debits éleves. Une perméabilite anormale de
l'epithélium tubulaire renal a l'inuline a été démontrée par micro-
injection. Des microponctions du debut et de Ia fin de nephrons
individuels ont démontré une diminution de reabsorption de fluide le
long du tubule contourné proximal des néphrons superficiels. Les
debits de fluide délivré au tubules proximal tardif et distal etaient
Clevés. Le debit de reabsorption de fluide dans l'anse de Henlé
superficielle était augmenté. L'osmolalité urinaire maximale et le
contenu tissulaire papillaire en urée étaient diminuCs. De Ia sorte, Ia
polyurie est dUe a une diminution de La reabsorption de fluide par les
tubules proximaux, et probablement par les canaux collecteurs papil-
laires. La diminution de Ia reabsorption proximale de fluide est probab-
lement secondaire a une anomalie de Ia reabsorption des solutés. Une
diminution de l'absorption de fluide dans Ic canal collecteur peut être
attribuée a la diminution observée de Ia concentration papillaire en
solutés.
Drugs that damage the kidney and reduce the rate of glomeru-
lar filtration may do so without reducing the rate of urine
excretion. In some types of acute renal failure, particularly in
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some experimental situations in which drug dosage and fluid
balance can be controlled, urine volume can increase when
filtration rate falls [1—4]. Gentamicin, an aminoglycoside antibi-
otic frequently used in patients with serious infections, is a drug
that can produce this syndrome of polyuric acute renal failure
[5—8].
The degree to which gentamicin affects the kidney varies with
the dose given and the time of exposure. In addition there are
definite strain and species differences in the doses which
achieve a given response. In the Sprague-Dawley strain of rat,
polyuria may occur with a dose as small as 10 mg/kg/day [9]. A
dose of 40 mg/kg/day in one study [9] and as much as 60
mg/kg/day [8] in another did not affect GFR. When 80 to 100
mg/kg/day is given for 10 to 14 days, acute renal failure (reduced
GFR and azotemia) and polyuria occur together with extensive
necrosis of the proximal convoluted epithelial cells [10, 111. In
Fischer 344 rats a dose as low as 40 mg/kg/day causes the
syndrome of polyuric acute renal failure [7, 12, 13]. In dogs 30
mg/kg/day produces such changes [14]. In each of these animals
there is a close temporal relationship between the severity of
the renal failure and the polyuria [9, 10, 12—14]. In humans,
gentamicin appears to produce acute renal failure in much the
same manner at doses of 3 to 5 mg/kg [6, 8]. Even the
occurrence of frank polyuria has been noted [15]. Thus, al-
though the species sensitivity to gentamicin nephrotoxicity
differs, the expression of that renal toxicity both morphological-
ly and functionally is similar in all species.
Yet there is controversy about the timing of the polyuria with
the fall in GFR. Cuppage et al [9] report polyuria without
reduced GFR, while Avasthi et al [161 report reduced GFR
without polyuria and both use 40 mg/kg in Sprague-Dawley rats.
In another study in which the Munich-Wistar rat was studied, a
modest reduction in GFR was observed before urine flow was
clearly increased [17]. A defect in maximum concentrating
ability may precede the polyuria, as well [10, 11]. Polyuria,
therefore, seems to be most consistently present after pro-
longed exposure to higher doses of gentamicin when GFR is
definitely reduced and azotemia clearly established [6, 11, 18].
Several recent studies in Sprague-Dawley rats have examined
the polyuria during gentamicin-induced renal failure. In one
study neither water deprivation nor vasopressin administration
restored urine volume to normal [18]. In clearance studies,
solute free water reabsorption [10] and free water clearance [111
were normal during the polyuria, suggesting normal thick
ascending limb solute transport. These studies did not identify
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the sites of impaired fluid reabsorption. We undertook the
present study to more closely examine nephron function during
gentamicin-induced polyuric renal failure. To be certain that
polyuria was a consistent feature, we administered 100 to 150
mg/kg gentamicin per day to the Sprague-Dawley strain of rat.
These animals were studied only after urine flow was clearly
increased.
Methods
Induction of polyuric acute renal failure
A total of 53 Sprague-Dawley rats were studied using three
protocols. All rats were placed in metabolic cages and were
given free access to water. They were fed 15 g of a standard rat
pellet diet (Mouse, Rat, and Hamster Formula, Charles River,
North Wilmington, Massachusetts) daily. After a 5-day period
of adjusting to their new environment, urine samples were
collected under oil in graduated plastic cylinders for 24-hr
periods; daily urine volume and osmolality were also deter-
mined. After a 3-day period, the rats were divided into two
groups. One group received 100 to 150 mg/kg gentamicin
intramuscularly daily in a single dose; the other group received
an equal volume of isotonic saline. When daily urine volume in
the gentamicin-treated group exceeded that in the control group
by 50% or more for 3 consecutive days, rats were studied using
one of three protocols described below. This induction period
usually lasted 10 to 14 days.
Preparation for micropuncture and microinjection
Polyuric and normal rats were anesthetized with mactin
(BYK Gulden, Konstanz, West Germany) 100 mg/kg i.p. and
placed on a heated surgical table. Body temperature was
monitored by a rectal temperature probe (Yellow Springs
Instruments Co., Inc., Yellow Springs, Ohio) and maintained at
37 to 38°C. Polyethylene catheters were placed in the right
external jugular vein and in the left internal carotid artery to
permit monitoring of arterial pressure continuously with a
strain-gauge transducer (Ailtech, City of Industry, California)
and recorder (Gould Inc., Cleveland, Ohio). A short polyethyl-
ene tube was placed in the trachea. The left kidney was exposed
through a flank incision and supported in a plastic cup after
carefully freeing it from the surrounding perirenal fat. The
kidney surface was bathed continuously with mineral oil
warmed to 37°C (YSI, Yellow Springs, Ohio), and the surface
was illuminated with a fiber optic illuminator fitted with an
infrared filter to minimize heat. The left ureter was cannulated
with a polyethylene catheter (0.28 mm I.D.); urine samples
were collected under oil into preweighed plastic tubes. Follow-
ing cannulation of the external jugular vein, isotonic NaCI-
NaHCO3 solution was infused intravenously at either 0.8 ml/hr
and per 100 g of body weight (free flow micropuncture studies)
or 2.0 ml/hr/lOO g of body weight (microinjection studies). No
attempt was made to replace surgical losses of fluid. In experi-
ments in which the recovery of microinjected inulin was ana-
lyzed, the urinary bladder was exposed by a low midline
abdominal incision; the bladder was cannulated by a polyethyl-
ene catheter inserted through an incision at the dome of the
bladder.
Free-flow micropuncture. A total of 27 (11 control and 16
gentamicin-treated) rats were studied. In these experiments the
infusion solution contained enough (methoxy-3H)-inulin (New
England Nuclear, Boston, Massachusetts) to deliver 150
pCi/hr. The first of two to four clearance periods was begun 100
mm after starting the infusion. Blood was collected in heparin-
ized microhematocrit tubes at the start of the first clearance
period and thereafter at 30-mm intervals throughout the course of
the experiments. The tubes were spun in a microhematocrit
centrifuge (International Equipment Co., Needham Heights,
Massachusetts), and the plasma was separated for later analy-
sis. Clearance periods lasted 60 to 90 mm. Because tubule fluid
flow rate varied from one nephron to another, fluid samples
were obtained from two sites in the same nephron. These sites
were identified by inserting a searching micropipet (tip O.D. 3
to 4 m) into a proximal tubule and injecting small volumes of a
solution of isotonic NaCl-NaHCO3 lightly colored with a green
dye (FD&C Green no. 3, Keystone Aniline and Chemical Co.,
Chicago, Illinois) (final concentration of 1 g/liter). By observing
the passage of the green fluid, the last proximal segment on the
surface was identified. This segment was then punctured with a
micropipet (tip O.D. 10 to 12 pm) filled with Sudan black
stained oil and a complete, timed collection of fluid was made.
The searching pipet remained within the lumen throughout the
collection. At the conclusion of the collection the searching
pipet was withdrawn, and earlier segments of the same nephron
were sought using the same pipet. Only nephrons having five
surface segments were used. During the collection of fluid from
these proximal tubules, special care was taken not to distend or
collapse the tubule. Surface distal tubules and late proximal
tubules belonging to the same nephron were punctured using
the same microperfusion technique described above. Distal
tubules were punctured with pipets having tip diameters of 8 to
10 &tm.
Proximal tubule microinjection. In these experiments five
control and seven gentamicin-treated rats were studied. (3H)
inulin was added to isotonic NaCIINaHCO3 to achieve a final
concentration of 1 mCi/mI. This solution, colored lightly with
FD&C green No. 3 dye, was placed between oil columns in a
constant bore quartz capillary tube of 100 jm I.D. Four-
nanoliter portions of this fluid measured with the aid of an
eyepiece micrometer were drawn into oil-filled pipets having
diameters of 7 to 10 m. A small quantity of mineral oil was
then aspirated into the tip. Alternately, these samples were
either injected into glass vials and used as reference standards
for total (3H) inulin injected or were injected into tubules. Urine
samples were collected for 15 mm before microinjection from
the left ureteral and bladder catheters to establish the back-
ground radioactivity. The pipet was then inserted into a proxi-
mal tubule segment chosen at random and a small volume of
tubule fluid was aspirated to clear the tip of oil. The fluid was
injected slowly over 2 to 3 mm. Care was taken to avoid
distention of the tubule, retrograde flow of colored fluid,
injection of oil, and leakage of the test solution. Only injections
which met these conditions were analyzed. After starting the
microinjection, urine samples were collected in scintillation
vials during four 15-mm intervals at which time counting rates
returned to background or added insignificantly to calculated
recoveries.
Tissue solute determination. A total of seven gentamicin-
treated, and seven control rats were studied. On the day of the
study no drinking water was provided and no drug (or vehicle)
was injected. Each rat was given 15 g of food and 1 U
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Table 1. Weights, bIood pressure, and plasma measurements in control and experimental ratsa
Body
weight
g
Blood
pressure
mm Hg
Hct
mildi
Na
mEqiliter
K
mEqiliter
Urea
mmoleslliter
Control (N =
Gentamicin (N
p
11) 225 12
= 16) 211 8
NS
107 2
107 8
NS
51 1
50 1
NS
141 1
144 1
NS
4.4 0.2
4.0 0.3
NS
7.5 0.7
22.9 2.5
<0.001
a Values are means SEM: N = number of animals studied in each group.
vasopressin (pitressin tannate in oil, Parke David & Co., Morris
Plains, New Jersey) was injected intramuscularly. Urine sam-
ples were collected under oil into graduated cylinders. In five
gentamicin and five control rats, the collections were divided
into two 12-hr collections. After 24 hr without water, the rats
were anesthetized with ether, and the kidneys were exposed via
a large midline abdominal incision. The kidneys were dissected
free from the surrounding fat and, in rapid sequence, the renal
pedicle was clamped and cut, and the kidneys were removed
and placed in a mixture of dry ice and acetone. Using a razor
blade, the frozen kidneys were then cut longitudinally, and the
exposed papilla was cut along its base to free it from the inner
medulla. Then tissue samples were taken from cortex, outer
medulla, and inner medulla. Mean tissue weights (± SEM in mg)
for cortex, outer medulla, inner medulla, and papilla were
(range) 61.9 10.3 (21.6 to 163.3), 21.9 1.8 (14.2 to 30.3), 13.7
1.0(7.8to 17.2),and4.81 0.57(2.8to 10.5)forcontrols;and
47.3 8.1 (20.8 to 98), 19.5 2.9 (11.5 to 40.6), 13.2 1.0 (9.1
to 17.9), and 6.01 0.64 (2.5 to 9.7) for gentamicin. Tissue
sample weight was not different statistically in the two groups.
In two rats each from the control and gentamicin-treated
groups, only cortical and papillary tissue were taken. The tissue
samples were placed in aluminum foil buckets which had been
cleaned and dried to constant weight beforehand. These sealed,
light weight buckets have been shown to increase the accuracy
of weighing tissue samples as small as 2 mg [19]. The buckets
were carefully sealed and weighed on an analytic balance
(Model 2502 Sartorius, Gottingen, Germany). The tissue sam-
ples were then treated in one of two ways. One set was removed
from the buckets and placed in preweighed glass homogenizing
tubes (TRI-R Instruments Inc., Rockville Center, New York)
containing 2.0 ml of deionized water and homogenized by hand.
The urea content of the slices was determined on the same day.
The other set was placed in an oven (100°C) and dried to
constant weight over 48 hr. The tissue was then placed in
preweighed test tubes containing 0.5 ml 16 M nitric acid and
digested at 100°C. After the addition of 1.5 ml deionized water
the tubes were reweighed and centrifuged. The diluted digests
were then analyzed for sodium and potassium.
Calculations
Single nephron inulin clearance (SNCIN) was calculated by
multiplying the ratio of tubule fluid to plasma radioactivity by
the measured flow rate of tubule fluid. Whole kidney clearance
of inulin was calculated by multiplying the ratio of urine to
plasma radioactivity by the measured flow rate of urine. Abso-
lute reabsorptive rates between late proximal tubule puncture
sites and distal puncture sites were calculated by subtracting
the measured flow rates at the distal puncture sites from the
measured flow rates of the late proximal tubule puncture site
within the same nephron. Absolute urinary excretion rates of
sodium, potassium, and urea were calculated by multiplying the
solute concentrations in urine by the volume flow rate of urine.
The recovery of microinjected 3H-inulin was calculated after
correcting the observed cpm for quench using the external
standards method. The dpm recovered in the urine were divided
by the dpm in the reference standards and expressed as percent
recovery. Tissue solute content was determined as the sum of
the measured sodium, potassium, and urea contents in the
digest divided either by the tissue water content or the tissue
dry weight. The water content of tissue was determined from
the difference between the wet and dry weights of the dessicat-
ed tissue samples. Osmotic concentration of measured solutes
in tissue water was estimated as the sum of urea concentration
plus 1.84 times the sum of sodium and potassium concentra-
tions [201.
Analytical methods
Total volumes of the tubular fluid collections were deter-
mined in a calibrated quartz-glass constant bore capillary (100
m I.D.) tube with the use of an eyepiece micrometer. 3H
activity in urine, tubule fluid, and plasma was determined in a
liquid scintillation spectrometer (Packard Tri-Carb Model 2425,
Downers Grove, Illinois). Only samples in which count rates
were three times above background were accepted. Sodium and
potassium in blood, urine, and tissue digests were determined
on a flame photometer (IL Model 143, Instrumentation Labora-
tory, Lexington, Massachusetts) which was standardized daily.
Appropriate standards bracketed the unknowns. Osmolality of
urine was determined by freezing-point depression (Fiske Asso-
ciates, Oxbridge, Massachusetts). Urea in plasma, urine, and
tissue was determined by the diacetyl monoxime as modified by
DiGiorgio [211 with standard curves drawn daily. Homogenates
were diluted to achieve urea nitrogen concentrations below 50
g/ml (O.D. 0.450) where the method is nearly linear.
Recovery of urea in tissue samples by this method was 98.6
1.7% (N = 16) from control kidneys and 103.3 4.4% (N = 8)
from gentamicin-treated kidneys.
Statistical analysis
The statistical significance of the results was assessed by the
Student t test with paired and unpaired data as indicated.
Equality among rat variance for SNGFR in control and genta-
micin-treated rats was tested by the F-test [22]. Significance
was indicated by a P value of 0.05 or less.
Results
Table 1 summarizes the general features of the control and
gentamicin rats studied by free-flow micropuncture. Body
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Table 2. Function of micropunctured kidney in control and gentamicin-treated rats
V
1.d/min U/P1
C1,
pi/min
[Na]u
mEqiliter
[K]u
mEqlliter
UNV
nEqimin
UKV
nEqlmin
Control (N =
Gentamicin (N
11)
= 16)
2.9 0.9
9.7 1.4
<0.001
416 79
30 4
<0.001
890 56
265 44
< 0.001
80 16
89 10
NS
299 39
88 8
< 0.001
310 128
953 205
< 0.025
630 66
763 80
NS
Early Late Early Late
proximal proximal proximal proximal
tubule tubule tubule tubule
Gentamicin Control
Fig. I. individual values for flow rate of tubule fluid (VTF) in early and
late segments of proximal tubules in gentamicin-treated and control
rats. Measurements performed in the same nephron are indicated by
open circles, those performed in different tubules are indicated by
closed circles, Solid lines indicate the mean values; hatched areas
indicate 1 SEM.
weights, blood pressures, and hematocrits were not different.
Plasma urea nitrogen concentration was significantly greater in
the gentamicin-treated group, while plasma sodium and potassi-
um were not significantly different from control.
Table 2 shows several manifestations of gentamicin nephro-
toxicity: increased urine flow, decreased (U/P)1, decreased
inulin clearance, and increased sodium excretion.
The appearance of the kidney surface in gentamicin-treated
animals was distinctly abnormal. The cell boundaries of the
tubular segments were ragged, and many nephrons had white
casts, presumably composed of cellular debris, within their
lumens. The luminal space was closed in some nephrons and
widely dilated in others. Occasionally, in nephrons with patent
lumens, debris could be seen flowing along the segments under
observation. In general, rats with higher plasma urea concentra-
tions had a greater number of closed, debris-filled nephrons. In
addition it was observed that microinjected fluid moved slowly
in some nephrons and rapidly in others. It was apparent that
with such variation from one tubule to another, random sam-
pling of nephrons alone would not be meaningful. For this
reason early and later segments of the same nephron were
studied. Many more nephrons were sampled where only an
early or later site was punctured.
In Figure 1 individual values are plotted for early and late
proximal tubule flow in gentamicin and control animals. In 16
gentamicin-treated animals 58 early and 59 later proximal
tubules were sampled. On the average, no fluid reabsorption
could be demonstrated between the two points of puncture. In
contrast, the expected fall in fluid flow rate was demonstrated
along control proximal tubules punctured in the same way.
Similarly, as shown in Figure 2, (TF/P)1 failed to increase
between these two proximal sites in the gentamicin-treated rats.
The expected increase in (TF/P)1 between the two proximal
sites was demonstrated in the control group. The delivery of
fluid out of the proximal convoluted tubule was significantly
higher in gentamicin-treated rats than that in control animals (P
> 0.001). The absence of fluid reabsorption is also noted when
only paired samples are compared (Table 3).
Calculated single nephron inulin clearance rates from all early
proximal tubule punctures in the gentamicin-treated animals
was 25.8 1.3 nI/mm, a value not significantly different from
the mean SNC1 measured in the control group (24.9 1.2
nl/min). A wide range of single nephron inulin clearance was
observed in the gentamicin group (7.1 to 63.4 nI/mm). The
variance of SNC1 in the gentamicin-treated animals was signifi-
cantly greater than that observed in the control animals (P <
0.005).
In Figure 3 individual values are shown for flow rates in distal
tubules from 8 control and 11 gentamicin-treated rats. In 23
punctures from the gentamicin-treated animals mean distal
tubular flow rate was 8.2 0.7 nl/min, significantly higher than
5.1 0.5 nI/mm measured in 23 punctures from the control
60 -
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E
>
3.0NS
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41o
22.8 1.2 20.4 1.3
P < 0.001
17.5 0.8 12.9 0.60
2.0
a-
U-
I—
NS
1.15 0.01 1.17 0.02
P<0.001 -
-
0
1.45 0.05 1.93 0.05
1.0
0
Early Late
proximal proximal
tubule tubule
Early Late
proximal proximal
tubule tubule
Gentamicin Control
Fig. 2. individual values for (TF/P) inulin in early and late segments of
proximal tubules in gentamicin-treated and control rats. Symbols are
the same as in Figure 1.
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Table 3. Paired measurements from early and late segments of single proximal tubules in control and gentamicin-treated rats
Number
rats/tubules
VTF, ni/mm (TF/P)In
EPT LPT EPT LPT
Control 9/19 16.9 1.1 12.9 1.1 1.49 0.06 1.90 0.12
P (early vs. late) < 0.001 < 0.001
Gentamicin 12/36 21.5 1.7 20.5 1.8 1.15 0.02 1.19 0.02
P (early vs. late) NS NS
P (control vs. gentamicin) NS <0.01 < 0.001 <0.001
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Fig. 4. Individual valuesfor recovery of inulin from left (microinjected)
and right (non-injected) kidney in control (0) and gentamicin-treated(5) rats.
ni/mm, a value not significantly different from the proximal flow
rates measured in nephrons without demonstrable distal tu-
bules, indicating that these nephrons were representative of the
functioning nephrons sampled in the study. Mean reabsorption
of fluid between these two sites was 13.3 1.6 nI/mm in
gentamicin-treated rats and was significantly higher than the 7.5
0.9 nl/min reabsorbed along the loop in control animals, (N =
8, P < 0.025). Calculated SNC1 in the distal tubule in these
paired punctures was significantly lower than that measured in
the proximal tubule in the gentamicin-treated animals (17.9
2.2 vs. 23.7 2.3 nI/mm, respectively, P < 0.025). This
Control Gentamicin
Fig. 3. Individual values for distal tubule fluid flow rates measured in
control (0) andgentamicin-treated (5) rats.
animals (P < 0.005). It was possible to sample fluid from the
late proximal tubule of the same nephron in 13 distal punctures
in the gentamicin-treated group and calculate the absolute rate
of reabsorption of fluid between these sites. The associated
proximal tubule flow rate in these distal tubules was 20.9 2.2
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Table 4. Urine flow and solute excretion during water restriction and vasopressin administration
V
ui/mm
Uosn,
sm/kg H20
UNaV UKV Uurea''
mO usi/min
Collection period 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd
Control 5.6 l.5b 2251 2926 1.8 Ø5b 1.9 0.6b 4.8 2.0"(N = 5) ±0.7 ±0.4 ±117 ±291 ±0.2 ±0.1 ±0.5 ±0.2 ±0.5 ±0.4
Gentamicin 12.5 6.4a 748a 1232a,h 1.2a 0.8 l.4 0.9" 4.8 4•4a(N = 5) ±1.3 ±0.7 ±50 ±173 ±0.2 ±0.1 ±0.2 ±0.03 ±0.7 ±0.3
Abbreviations: 1st and 2nd refer to 12-hr urine collection periods during 24 hr of water restriction; N, number of rats in each group.
a The mean value is significantly different from control.
b The mean value is significantly different from the 1st 12-hr values.
disparity was not as large in the control animals (20.7 ± 2.1
distal, vs. 23.9 ± 1.9 proximal, P > 0.1).
The results of the microinjection studies are shown in Figure
4. Mean recovery of microinjected inulin (left kidney) in the
gentamicin group (seven animals), while quite variable, was
significantly lower than that observed in control animals (five
animals) (70 ± 7 vs. 96 = 2%, P K 0.025). Recovery of inulin
from the contralateral (right) ureter in the gentamicin group was
significantly higher than in control animals (P < 0.005).
Table 4 gives urinary data collected during the period of
dehydration in control and gentamicin-treated rats. The genta-
micin rats remained polyuric throughout the period of dehydra-
tion, although the extent of the polyuria diminished as dehydra-
tion proceeded. The increased urine flow was associated with a
greater weight loss in the gentamicin-treated rats than that
experienced by controls (22.4 vs. 8.0 g, P K 0.001). Urinary
osmolality was significantly lower in both collection periods
compared to control, but rose between the first and second
collection periods. The gentamicin-treated rats were unable to
lower the rate of excretion of urea and sodium in the second 12-
hr period of dehydration. In marked contrast, urea and sodium
excretion decreased in the control rats.
Figure 5 depicts the tissue sodium and urea content from
cortex, outer medulla, inner medulla, and papilla at the conclu-
sion of the dehydration period. Although the cortical to inner
medullary gradients for sodium and urea were intact in the
gentamicin-treated animals, papillary urea content was reduced
profoundly. Papillary sodium content fell modestly. Calculated
papillary osmolality fell from 1446 ± 104 in controls to 833 ± 97
mOsm/kg H20 in gentamicin-treated rats (P < 0.005). Tissue
water content in the gentamicin-treated group exceeded that in
the control in cortex (82 ± 1 in gentamicin vs. 78 ± 1 in control,
P K 0.01) and outer medullary tissue (88 ± 0.3 vs. 86 ± 1, P <
0.025). Water content of the inner medulla and papilla was the
same for the two groups.
Discussion
The present studies were designed to examine whole kidney
and single nephron function when reduced inulin clearance,
azotemia, and polyuria coincide following prolonged exposure
to gentamicin. A previous study has examined factors contrib-
uting to the fall in glomerular filtration seen after a shorter
period of gentamicin exposure and before the appearance of
polyuria and azotemia [17]. In that study as little as 4 mg/kg of
body weight of gentamicin was given for 10 days; SNGFR was
found to be reduced uniformly. In the present studies, however,
SNGFR was not uniformly reduced. Reduced whole kidney
inulin clearance was a consequence of both reduced numbers of
filtering nephrons and leakage of inulin across tubule walls. It is
likely that the differences between these two studies are real
and reflect the different degrees of gentamicin nephrotoxicity
studied. Azotemia, polyuria, and cell necrosis seen in the
present study are more typical of the later stages of gentamicin
nephrotoxicity in rats [7, 9, 12, 131. Thus, while the initial event
in gentamicin-induced renal failure seems to be reduced filtra-
tion in all nephrons later on, when proximal cell necrosis
accompanies the fall in glomerular filtration, filtration may
cease altogether in some nephrons while in others filtration may
continue even at supernormal rates. The factors which sustain
filtration in some nephrons but not others are unknown.
Our studies indicate that gentamicin-treated animals were
polyuric despite the reduced numbers of filtering nephrons.
Two additional defects in renal function were found to accom-
pany the polyuria. First, fluid reabsorption was diminished
along the proximal convoluted tubule (Fig. 1, Table 3). This was
true whether tubule fluid flow rates were high or low. This
defect may be due to the extensive cell damage gentamicin
produces at this nephron site [8, 12, 23]. Appearance in the
urine of glucose [241, protein, and enzyme markers of proximal
tubular epithelial cell damage [8, 23] are other indicators of
proximal tubule damage. Extensive cell damage may limit the
capacity of the proximal tubule cells to reabsorb solutes and,
since this is the basis for fluid absorption in the proximal
tubules, thereby lead to diminished fluid reabsorption. Alterna-
tively, the diminished proximal convoluted tubule reabsorption
may be due to the uremia [25] which accompanies this phase of
the disease. Several pieces of information argue against this
explanation. Fractional fluid reabsorption along the proximal
convoluted tubule is normal in several other forms of nephro-
toxic renal failure at comparable degrees of azotemia [2, 4, 26].
Using micropuncture techniques Biber et al [2] have demon-
strated reduced proximal water reabsorption after K2Cr2O7, a
toxin which damages the proximal convoluted tubule, and
normal proximal water reabsorption after HgCl2 administration,
a toxin which damages the straight portion of the proximal
tubule inaccessible to micropuncture. Thus structure and func-
tion correlated perfectly. Therefore, the most likely cause of
reduced proximal fluid reabsorption seems to be the severe
morphologic damage produced by gentamicin to this portion of
the nephron.
Second, the gentamicin-treated rats failed to accumulate
solute, particularly urea, in the papillary interstitium (Fig. 5).
This defect was not corrected by administration of vasopressin
or by prolonged dehydration. The cause for this failure to
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Fig. 5. Sodium and urea concentrations in tissue samples from control
and gentamicin-treated rats. Tissue solute concentration is expressed
in mmoles/kgH2O in upper panel and mmoles/100 g dry solid in lower
panel. The asterisk represents P value < 0.05.
concentrate solute in the papilla is much less clear since
gentamicin produces no consistent morphologic damage to this
area of the kidney [7, 12, 23]. Although high rates of flow out of
functioning superficial nephrons was observed in this study, a
similar reduction in papillary solute content was observed in
rats treated with cisplatin where the polyuria was associated
with a reduced rate of flow in superficial nephrons [4]. Thus
changes in superficial nephron fluid flow rates may not be
causally linked to the low solute content in the papilla. The
ability to reabsorb water, and presumably solute, in Henle's
loop of superficial nephrons appears to be intact as evidenced
by the reabsorption of fluid in the loop of Henle of the
gentamicin-treated animals seen in this study, and the normal
rates of free water clearance and reabsorption shown by others
[10, 11]. Other explanations for the lower solute concentration
in the papilla such as diminished collecting duct responsiveness
to vasopressin produced by uremia [27] and increased papillary
blood flow are possible. Regardless of the mechanism by which
solute in the papilla is reduced, such reduced solute concentra-
tion in the renal papilla would limit the capacity of the collecting
ducts to reabsorb fluid.
The present results suggest, therefore, that gentamicin-in-
duced polyuria is the result of at least two defects. Proximal
tubule fluid reabsorption is markedly reduced. Second, papil-
lary solute content is reduced. This low papillary solute concen-
tration would limit the capacity for water reabsorption from the
papillary collecting ducts. So long as filtration is present in
enough nephrons these defects in absorptive capacity can
produce polyuria. While the cause of reduced proximal reab-
sorption is most probably related to gentamicin-induced cell
necrosis, the cause of reduced papillary solute content in the
medulla is not known.
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